NBS
MCID: NJM001
MIFTS: 67

Nijmegen Breakage Syndrome (NBS) malady

Categories: Genetic diseases, Rare diseases, Fetal diseases, Blood diseases, Immune diseases

Aliases & Classifications for Nijmegen Breakage Syndrome

About this section
Sources:
2CDC, 11Disease Ontology, 12diseasecard, 13DISEASES, 23GeneReviews, 24GeneTests, 25Genetics Home Reference, 27GTR, 31ICD10 via Orphanet, 37MedGen, 39MeSH, 40MESH via Orphanet, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 52OMIM, 54Orphanet, 62SNOMED-CT, 64The Human Phenotype Ontology, 68UMLS, 69UMLS via Orphanet, 70UniProtKB/Swiss-Prot
See all MalaCards sources

Aliases & Descriptions for Nijmegen Breakage Syndrome:

Name: Nijmegen Breakage Syndrome 52 11 23 48 24 25 54 70 12 50 39 13 68
Berlin Breakage Syndrome 11 48 24 25 54
Nbs 54 70 2
Immunodeficiency, Microcephaly with Normal Intelligence 48 27
Microcephaly, Normal Intelligence and Immunodeficiency 11 25
Ataxia-Telangiectasia Variant 1 24 25
Seemanova Syndrome 11 25
Microcephaly with Normal Intelligence Immunodeficiency and Lymphoreticular Malignancies 48
Nonsyndromal Microcephaly Autosomal Recessive with Normal Intelligence 48
 
Immunodeficiency-Microcephaly-Chromosomal Instability Syndrome 54
Microcephaly-Immunodeficiency-Lymphoreticuloma Syndrome 54
Microcephaly Immunodeficiency Lymphoreticuloma 48
Ataxia-Telangiectasia, Variant 1 54
Ataxia-Telangiectasia Variant V1 48
Seemanova Syndrome Type 2 54
Seemanova Syndrome 2 48
at V1 54
at-V1 24

Characteristics:

Orphanet epidemiological data:

54
nijmegen breakage syndrome:
Inheritance: Autosomal recessive; Age of onset: Infancy,Neonatal

HPO:

64
nijmegen breakage syndrome:
Inheritance: autosomal recessive inheritance

Classifications:



External Ids:

OMIM52 251260
Disease Ontology11 DOID:7400
MeSH39 D049932
NCIt45 C4692
Orphanet54 ORPHA647
SNOMED-CT62 234638009
MESH via Orphanet40 C531759, D049932
ICD10 via Orphanet31 Q87.8
UMLS via Orphanet69 C0398791, C2930831

Summaries for Nijmegen Breakage Syndrome

About this section
OMIM:52 The Nijmegen breakage syndrome and the phenotypically indistinguishable Berlin breakage syndrome are autosomal... (251260) more...

MalaCards based summary: Nijmegen Breakage Syndrome, also known as berlin breakage syndrome, is related to nijmegen breakage syndrome-like disorder and neuroblastoma, and has symptoms including Array, Array and Array. An important gene associated with Nijmegen Breakage Syndrome is NBN (Nibrin), and among its related pathways are Telomere Extension by Telomerase and TP53 Network. Affiliated tissues include t cells, b cells and breast, and related mouse phenotypes are Increased viability with MLN4924 (a NAE inhibitor) and Synthetic lethal with MLN4924 (a NAE inhibitor).

Genetics Home Reference:25 Nijmegen breakage syndrome is a condition characterized by short stature, an unusually small head size (microcephaly), distinctive facial features, recurrent respiratory tract infections, an increased risk of cancer, intellectual disability, and other health problems.

UniProtKB/Swiss-Prot:70 Nijmegen breakage syndrome: A disorder characterized by chromosomal instability, radiation sensitivity, microcephaly, growth retardation, immunodeficiency and predisposition to cancer, particularly to lymphoid malignancies.

Wikipedia:71 Nijmegen breakage syndrome (NBS), also known as Berlin breakage syndrome, ataxia telangiectasia variant... more...

GeneReviews for NBK1176

Related Diseases for Nijmegen Breakage Syndrome

About this section

Diseases in the Nijmegen Breakage Syndrome family:

Nijmegen Breakage Syndrome-Like Disorder

Diseases related to Nijmegen Breakage Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 67)
idRelated DiseaseScoreTop Affiliating Genes
1nijmegen breakage syndrome-like disorder12.6
2neuroblastoma11.7
3leukemia, acute promyelocytic, somatic11.1
4nicolaides-baraitser syndrome10.9
5ataxia10.5
6ataxia-telangiectasia10.5
7leukemia10.3
8lymphoma10.3
9breast cancer10.2
10lymphoblastic leukemia10.2
11microcephaly10.2
12lethal congenital contracture syndrome 710.2BRCA1, NBN
13lung clear cell-sugar-tumor10.1BRCA1, TP53
14lymphoproliferative syndrome, ebv-associated, autosomal, 110.1CHEK2, TP53
15breast pericanalicular fibroadenoma10.1BRCA1, TP53
16medulloblastoma10.1
17paraphimosis10.1BRCA1, TP53
18childhood brain stem glioma10.1ATM, TP53
19postpartum depression10.1BRCA1, TP53
20bladder colloid adenocarcinoma10.1BRCA1, TP53
21uterine corpus endometrial stromal sarcoma10.0BRCA1, TP53
22villoglandular endometrial endometrioid adenocarcinoma10.0ATM, BRCA1, TP53
23intraorbital meningioma10.0ATM, BRCA1, TP53
24porencephaly 110.0ATM, LIG4, NBN
25prostate cancer10.0
26hodgkin lymphoma10.0
27prostatitis10.0
28bacteremia10.0BRCA1, MRE11
29bronchogenic cyst10.0ATM, BRCA1, CHEK2
30polyembryoma of the ovary10.0ATM, BRCA1, CHEK2
31hidradenoma9.9BRCA1, LIG4, TP53
32recombinase activating gene 1 deficiency9.9H2AFX, LIG4
33bronchiectasis oligospermia9.9ATM, BRCA1, CHEK2, NBN
34rheumatoid arthritis9.9
35lung cancer9.9
36hiv-19.9
37schizencephaly9.9
38hepatocellular carcinoma9.9
39aplastic anemia9.9
40insulin-like growth factor i9.9
41bloom syndrome9.9
42acute monocytic leukemia9.9
43arthritis9.9
44b-cell lymphomas9.9
45prolymphocytic leukemia9.9
46rhabdomyosarcoma9.9
47porokeratosis9.9
48thrombophlebitis9.9
49tuberculosis9.9
50intrahepatic cholangiocarcinoma9.9

Graphical network of the top 20 diseases related to Nijmegen Breakage Syndrome:



Diseases related to nijmegen breakage syndrome

Symptoms & Phenotypes for Nijmegen Breakage Syndrome

About this section

Symptoms by clinical synopsis from OMIM:

251260

Clinical features from OMIM:

251260

Human phenotypes related to Nijmegen Breakage Syndrome:

 54 64 (show all 74)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 cleft palate64 54 Occasional (29-5%) HP:0000175
2 microcephaly64 54 Very frequent (99-80%) HP:0000252
3 abnormality of the face54 Very frequent (99-80%)
4 retrognathia64 54 Very frequent (99-80%) HP:0000278
5 low anterior hairline64 54 Very frequent (99-80%) HP:0000294
6 sloping forehead64 54 Very frequent (99-80%) HP:0000340
7 hearing abnormality64 54 Very frequent (99-80%) HP:0000364
8 macrotia64 54 Very frequent (99-80%) HP:0000400
9 prominent nasal bridge64 54 Very frequent (99-80%) HP:0000426
10 convex nasal ridge64 54 Very frequent (99-80%) HP:0000444
11 prominent nose64 54 Very frequent (99-80%) HP:0000448
12 short neck64 54 Very frequent (99-80%) HP:0000470
13 abnormality of the eyelid54 Occasional (29-5%)
14 upslanted palpebral fissure64 54 Very frequent (99-80%) HP:0000582
15 cutaneous photosensitivity64 54 Occasional (29-5%) HP:0000992
16 mental deterioration64 54 Very frequent (99-80%) HP:0001268
17 muscle weakness64 54 Occasional (29-5%) HP:0001324
18 freckling64 54 Occasional (29-5%) HP:0001480
19 abnormality of the hair54 Very frequent (99-80%)
20 thrombocytopenia64 54 Very frequent (99-80%) HP:0001873
21 hemolytic anemia54 Very frequent (99-80%)
22 autoimmune hemolytic anemia64 54 Very frequent (99-80%) HP:0001890
23 deep philtrum64 54 Very frequent (99-80%) HP:0002002
24 anal atresia64 54 Very frequent (99-80%) HP:0002023
25 anal stenosis64 54 Very frequent (99-80%) HP:0002025
26 chronic diarrhea64 54 Very frequent (99-80%) HP:0002028
27 recurrent respiratory infections54 Very frequent (99-80%)
28 abnormality of neuronal migration64 54 Occasional (29-5%) HP:0002269
29 acute leukemia64 54 Occasional (29-5%) HP:0002488
30 neoplasm54 Frequent (79-30%)
31 lymphoma64 54 Occasional (29-5%) HP:0002665
32 rhabdomyosarcoma64 54 Occasional (29-5%) HP:0002859
33 respiratory failure64 54 Occasional (29-5%) HP:0002878
34 abnormality of the musculature54 Occasional (29-5%)
35 skeletal muscle atrophy64 54 Occasional (29-5%) HP:0003202
36 abnormality of chromosome stability64 54 Very frequent (99-80%) HP:0003220
37 short stature64 54 Very frequent (99-80%) HP:0004322
38 cachexia64 54 Very frequent (99-80%) HP:0004326
39 depressed nasal bridge64 54 Very frequent (99-80%) HP:0005280
40 recurrent sinopulmonary infections64 54 Very frequent (99-80%) HP:0005425
41 recurrent pneumonia64 54 Very frequent (99-80%) HP:0006532
42 attention deficit hyperactivity disorder64 54 Very frequent (99-80%) HP:0007018
43 glioma64 54 Occasional (29-5%) HP:0009733
44 abnormal hair quantity64 54 Very frequent (99-80%) HP:0011362
45 t-cell lymphoma64 54 Occasional (29-5%) HP:0012190
46 b-cell lymphoma64 54 Occasional (29-5%) HP:0012191
47 anorectal anomaly54 Very frequent (99-80%)
48 non-midline cleft lip64 54 Occasional (29-5%) HP:0100335
49 pollakisuria64 54 Frequent (79-30%) HP:0100515
50 recurrent urinary tract infections64 HP:0000010
51 hydronephrosis64 HP:0000126
52 cleft upper lip64 HP:0000204
53 sinusitis64 HP:0000246
54 mastoiditis64 HP:0000265
55 micrognathia64 HP:0000347
56 otitis media64 HP:0000388
57 choanal atresia64 HP:0000453
58 hyperactivity64 HP:0000752
59 cafe-au-lait spot64 HP:0000957
60 intellectual disability64 HP:0001249
61 intrauterine growth retardation64 HP:0001511
62 primary ovarian failure64 HP:0001587
63 diarrhea64 HP:0002014
64 bronchiectasis64 HP:0002110
65 neurodegeneration64 HP:0002180
66 recurrent bronchitis64 HP:0002837
67 medulloblastoma64 HP:0002885
68 dysgammaglobulinemia64 HP:0002961
69 long nose64 HP:0003189
70 recurrent infection of the gastrointestinal tract64 HP:0004798
71 decrease in t cell count64 HP:0005403
72 progressive vitiligo64 HP:0005602
73 malar prominence64 HP:0010620
74 b lymphocytopenia64 HP:0010976

GenomeRNAi Phenotypes related to Nijmegen Breakage Syndrome according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00250-A-36.3ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1
2GR00250-A-11.3ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1

MGI Mouse Phenotypes related to Nijmegen Breakage Syndrome according to GeneCards Suite gene sharing:

41 (show all 11)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053808.8ATM, BRCA1, MRE11, NBN, RAD50, TP53
2MP:00036317.8ATM, BRCA1, CHEK2, LIG4, MRE11, NBN
3MP:00053787.3ATM, BRCA1, H2AFX, LIG4, MDC1, NBN
4MP:00020066.9ATM, BRCA1, CHEK2, H2AFX, LIG4, MRE11
5MP:00053796.8ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1
6MP:00053896.8ATM, BRCA1, H2AFX, LIG4, MDC1, MRE11
7MP:00053766.6ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1
8MP:00053846.4ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1
9MP:00053976.4ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1
10MP:00053876.3ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1
11MP:00107686.3ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1

Drugs & Therapeutics for Nijmegen Breakage Syndrome

About this section

Drugs for Nijmegen Breakage Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 64)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Dexamethasoneapproved, investigational, vet_approvedPhase 4217150-02-25743
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
137098-19-2
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16α-Methyl-9α-fluoro-1-dehydrocortisol
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-fluoro-16alpha-methyl-Prednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
AI3-50934
Adexone
Aeroseb-D
Aeroseb-Dex
Aeroseb-dex
Ak Dex Oph Otic Soln 0.1%
Alcon Brand of Dexamethasone
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (Veterinary)
Azium (veterinary)
BIDD:ER0494
BIDD:PXR0060
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
Bisu DS
Bisu Ds
C15643
C22H29FO5
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
CPD-10549
CPD001227192
Calonat
Corson
Corsone
Cortisumman
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
DEX
DEXA
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
DXM
DXMS
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-LA
Decadron-La
Decagel
Decaject
Decaject L.A.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [DCIT]
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
Dex-Ide
Dex-ide
Dexa
Dexa Mamallet
Dexa mamallet
Dexa-Cortidelt
Dexa-Cortisyl
Dexa-Mamallet
Dexa-Scheroson
Dexa-Sine
Dexa-cortidelt
Dexa-cortisyl
Dexa-scheroson
Dexa-sine
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexacortin
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
 
Dexameth
Dexamethansone
Dexamethasone
Dexamethasone (JP15/USP/INN)
Dexamethasone Acetate
Dexamethasone Alcohol
Dexamethasone Base
Dexamethasone Intensol
Dexamethasone Sodium Phosphate
Dexamethasone [INN:BAN:JAN]
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexason
Dexasone
Dexasone 0.5mg
Dexasone 0.75mg
Dexasone 4mg
Dexasporin
Dexinolon
Dexinoral
Dexone
Dexone 0.5
Dexone 0.75
Dexone 1.5
Dexone 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
Dxms
ECR Brand of Dexamethasone
EINECS 200-003-9
FT-0080377
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy Brand of Dexamethasone
Gammacorten
HL-dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
Hexadecadrol
Hexadrol
Hexadrol Elixir
Hexadrol Tablets
Hexadrol elixir
Hl-Dex
Hl-dex
I06-1196
ICN Brand of Dexamethasone
IontoDex
Isopto-Dex
Isopto-dex
LS-7300
Lokalison F
Lokalison f
Loverine
Luxazone
MK 125
MLS001055412
MLS001332507
MLS001332508
Maxidex
Maxidex Ont 0.1%
Maxidex Sus 0.1%
Maxitrol
Mediamethasone
Merck Brand of Dexamethasone
Merz Brand 1 of Dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MolMap_000018
MolPort-003-846-433
Mymethasone
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
NCI60_003067
NSC 34521
NSC34521
Naquasone (veterinary)
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
OTO-104
Ocu-Trol
Ocu-trol
Oradexon
PHL-dexamethasone
PMS-dexamethasone
Pet Derm III
Pet Derm Iii
Pet derm III
Pet-Derm Iii
Pms Dexamethasone Elixir 0.5mg/5ml
Policort
Posurdex
Prednisolon F
Prednisolon f
Prednisolone F
Prednisolone f
Prodex
S1322_Selleck
SAM002548948
SGCUT00126
SK-Dexamethasone
SK-dexamethasone
SMP1_000092
SMR000857119
SMR001227192
ST50307091
Sandoz dexamethasone
Sk-Dexamethasone
Spectrum5_002019
Spoloven
Sunia Sol D
Sunia sol D
Superprednol
TL8003317
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
alpha -Fluoro-16-alpha -methylcortisol
delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
dexamethasone
nchembio809-comp2
to_000038
2
RanibizumabapprovedPhase 4486347396-82-1459903
Synonyms:
347396-82-1
D05697
Lucentis
Lucentis (TN)
 
Ranibizumab
Ranibizumab (USAN/INN)
Ranibizumab (genetical recombination)
Ranibizumab (genetical recombination) (JAN)
ranibizumab
rhuFab V2
3Angiogenesis InhibitorsPhase 44257
4HIV Protease InhibitorsPhase 45470
5HormonesPhase 414415
6Peripheral Nervous System AgentsPhase 4, Phase 323689
7
protease inhibitorsPhase 45471
Synonyms:
 
protease inhibitors
8Pharmaceutical SolutionsPhase 4, Phase 38192
9glucocorticoidsPhase 45103
10Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 413168
11Hormone AntagonistsPhase 413180
12Antineoplastic Agents, HormonalPhase 4, Phase 35592
13Anti-Inflammatory AgentsPhase 410729
14AntiemeticsPhase 44022
15Gastrointestinal AgentsPhase 4, Phase 38402
16Autonomic AgentsPhase 410150
17Angiogenesis Modulating AgentsPhase 44185
18BB 1101Phase 42171
19Dexamethasone acetatePhase 421711177-87-3
20Dexamethasone 21-phosphatePhase 42171
21histidineNutraceuticalPhase 445
22
Carbamazepineapproved, investigationalPhase 3132298-46-42554
Synonyms:
2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
298-46-4
5-Carbamoyl-5H-dibenz(b,f)azepine
5-Carbamoyl-5H-dibenz[b,F]azepine
5-Carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenzo(b,F)azepine
5-Carbamoyl-5H-dibenzo(b,f)azepine
5-Carbamoyldibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,F)azepine
5-Carbamyl-5H-dibenzo(b,f)azepine
5-Carbamyldibenzo(b,f)azepine
5H-Dibenz(b,F)azepine-5-carboxamide
5H-Dibenz(b,f)azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5- carboxamide
5H-Dibenz[b,f]azepine-5-carboxamide
5H-Dibenzo[b,f]azepine-5-carboxamide
85756-57-6 (di-hydrate)
AC-10560
AC1L1DXT
AC1Q4ZSU
AC1Q4ZSV
AKOS003235644
Amizepin
Amizepine
Apo-Carbamazepine
Atretol
BIDD:GT0479
BIM-0050280.0001
BPBio1_000225
BRD-K71799949-001-06-7
BRN 1246090
BSPBio_000203
BSPBio_001929
Bio-0751
Bipotrol
Biston
C 4024
C06868
C4024_SIAL
C4024_SIGMA
C8981_SIAL
CARBAMAZEPINE, U.S.P.
CAS-298-46-4
CBChromo1_000350
CBZ
CDS1_002710
CHEBI:3387
CHEMBL108
CID2554
CPD001227191
Calepsin
Carbamazepan
Carbamazepen
Carbamazepin
Carbamazepina
Carbamazepina [INN-Spanish]
Carbamazepine (JP15/USP/INN)
Carbamazepine [USAN:INN:BAN:JAN]
Carbamazepinum
Carbamazepinum [INN-Latin]
Carbamazépine
Carbamezepine
Carbatrol
Carbatrol extended-release
Carbazepin
Carbazepine
Carbelan
ChemDiv1_018966
D00252
DB00564
DivK1c_000388
DivK1c_003750
EINECS 206-062-7
EU-0100292
Epitol
Epitol, Equetro, Tegretol, Biston, Calepsin, Carbamazepine
Equetro
Equetro (TN)
Finlepsin
G 32883
G-32883
Geigy 32883
HMS1568K05
 
HMS1920I17
HMS2090M07
HMS2091O19
HMS501D10
HMS640O02
HSDB 3019
I06-0863
IDI1_000388
KBio1_000388
KBio2_000516
KBio2_003084
KBio2_005652
KBio3_001149
KBioGR_000724
KBioSS_000516
Karbamazepin
LS-60362
Lexin
Lopac-C-4024
Lopac0_000292
MLS000069652
MLS001055475
MLS001074172
MolPort-000-710-574
NCGC00015234-01
NCGC00015234-02
NCGC00015234-03
NCGC00015234-07
NCGC00015234-13
NCGC00023877-03
NCGC00023877-04
NCGC00023877-05
NCGC00023877-06
NCGC00023877-07
NCGC00023877-08
NINDS_000388
NSC 169864
NSC169864
Neurotol
Neurotop retard
Novo-Carbamaz
Nu-Carbamazepine
Oprea1_790775
Prestwick0_000052
Prestwick1_000052
Prestwick2_000052
Prestwick3_000052
Prestwick_104
S1693_Selleck
SAM002264603
SMR000058201
SMR001227191
SPBio_000170
SPBio_002124
SPD-417
SPECTRUM1500159
STK177357
Sirtal
Spectrum2_000125
Spectrum3_000325
Spectrum4_000262
Spectrum5_000936
Spectrum_000096
Stazepin
Stazepine
Taro-Carbamazepine
Taro-Carbamazepine Cr
Tegretal
Tegretol
Tegretol (TN)
Tegretol Chewtabs
Tegretol Cr
Tegretol-Xr
Telesmin
Teril
Timonil
Trimonil
UNII-33CM23913M
WLN: T C676 BNJ BVZ
ZINC00004785
benzo[b][1]benzazepine-11-carboxamide
carbamazepine
carbamazepine (Tegretol)
nchem.859-comp7
23PiracetamapprovedPhase 31757491-74-9
24
Valproic Acidapproved, investigationalPhase 332799-66-13121
Synonyms:
(N-C3H7)2CHCOOH
(S)-2-propyl-4-pentanoate
(S)-2-propyl-4-pentanoic acid
2 PP (base)
2-N-Propyl-N-valeric acid
2-Propyl-Pentanoate
2-Propyl-Pentanoic acid
2-Propylpentanoate
2-Propylpentanoic Acid
2-Propylpentanoic acid
2-Propylvaleric Acid
2-Propylvaleric acid
2-n-Propyl-n-valeric acid
2-n-propyl-n-valeric acid
2-propyl-pentanoic acid
2-propylvaleric acid
4-Heptanecarboxylic acid
4-heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
AC1L1F7T
AC1Q2ULA
AI3-10500
APO-divalproex
Abbott 44090
Acide valproique
Acide valproique [INN-French]
Acide valproique [inn-french]
Acido valproico
Acido valproico [INN-Spanish]
Acido valproico [inn-spanish]
Acidum valproicum
Acidum valproicum [INN-Latin]
Acidum valproicum [inn-latin]
Alti-Valproic
Alti-valproic
Apo-valproic
Apo-valproic syrup
Avugane
BIDD:GT0858
BRN 1750447
Baceca
C07185
CHEBI:39867
CHEMBL109
CID3121
CPD000499581
Convulex
Convulsofin
D00399
DB00313
DOM-divalproex
DOM-valproic
DOM-valproic acid E.C.
DPA
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Deproic
Di-N-propylacetic acid
Di-N-propylessigsaure
Di-N-propylessigsaure [german]
Di-n-propylacetic acid
Di-n-propylessigsaeure
Di-n-propylessigsaure
Di-n-propylessigsaure [German]
Di-n-propylessigsäure
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
DivK1c_000273
Divalproex
Dom-Valproic
Dom-valproate
Dom-valproic acid
Dom-valproic acid syrup
EINECS 202-777-3
Epiject I.V.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
KBio2_004845
 
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
MLS001076682
MLS001335927
MLS001335928
MLS002415770
Med Valproic
Med valproic
MolPort-001-791-895
Mylproin
Myproate
Myproic Acid
Myproic acid
N-DPA
N-Dipropylacetic acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
NINDS_000273
NSC 93819
NSC93819
Novo-Valproic
Novo-Valproic - ECC
Novo-divalproex
Novo-valproic
Novo-valproic soft gel cap
Nu-Valproic
Nu-valproic
P0823
P6273_SIGMA
PEAC
PHL-valproate
PHL-valproic acid
PHL-valproic acid E.C.
PMS-Divalproex
PMS-Valproic Acid
PMS-valproate
PMS-valproic acid
PMS-valproic acid E.C.
Penta-Valproic
Penta-valproic
Propylvaleric acid
Ratio-Valproic - ECC
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
SBB065764
SMR000499581
SPBio_000912
Sandoz valproic
Savicol
Semisodium Valproate
Sodium hydrogen divalproate
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Spectrum_000521
Sprinkle
Stavzor
UNII-614OI1Z5WI
VALPROIC ACID
VPA
Valcote
Valparin
Valproate
Valproate semisodique [French]
Valproate semisodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
Valproic Acid, Sodium Salt (2:1)
Valproic acid
Valproic acid (USP)
Valproic acid USP
Valproic acid USP24
Valproic acid [USAN:INN:BAN]
Valproic acid [usan:ban:inn]
Valproinsaeure
Valproinsäure
Vupral
WLN: QVY3 & 3
acide valproïque
acidum valproicum
di-n-propylacetic acid
n-DPA
n-Dipropylacetic acid
nchembio.79-comp4
nchembio815-comp21
valproate
valproic acid
ácido valproico
25
LacosamideapprovedPhase 379860352-01-8, 175481-36-4219078
Synonyms:
( )-(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide
(2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide
(2R)-2-acetamido-N-benzyl-3-methoxypropanamide
175481-36-4
AC1L560M
ADD 234037
ADD-234037
AKOS005146274
AZD7762
CHEBI:188739
CHEMBL58323
CID219078
D07299
 
Erlosamide
Erlosamide [INN]
Erlosamide, Vimpat, Lacosamide
Harkoseride
I01-7424
LS-185541
Lacosamide
Lacosamide (USAN/INN)
Lacosamide [USAN]
S1253_Selleck
SPM 927
SPM-927
SPM-929
Vimpat
ZINC00007673
26
Octreotideapproved, investigationalPhase 322383150-76-9383414, 6400441
Synonyms:
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
79517-01-4 (acetate salt)
83150-76-9
AC1L1GVU
AC1L8LCD
AC1L9M4X
C07306
C5H12O2.C4H10
CHEBI:427278
CHEBI:611465
CHEMBL1680
CID383414
CID448601
CID54374
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide
D00442
DRG-0115
HMS2090C09
HS-2020
 
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*
L000453
LS-177735
LS-187135
Longastatin
NCGC00181796-01
NCI60_025753
Octreotida
Octreotida [Spanish]
Octreotide
Octreotide (USAN/INN)
Octreotide Acetate Salt
Octreotide [USAN:INN:BAN]
Octreotide-LAR
Octreotidum
Octreotidum [Latin]
Octrotide
SAN 201-995
SM 201-995
SMS 201-995
SMS-201-995
Sandostatine
Sandoz 201-995
UNII-RWM8CCW8GP
nchembio.184-comp3
zacycloicosane-4-carboxamide acetate
27Nootropic AgentsPhase 3716
28Psychotropic DrugsPhase 36430
29Tranquilizing AgentsPhase 34265
30Protective AgentsPhase 37443
31Neurotransmitter AgentsPhase 318340
32AnticonvulsantsPhase 32695
33Neuroprotective AgentsPhase 31716
34AnalgesicsPhase 311733
35Antimanic AgentsPhase 3814
36Analgesics, Non-NarcoticPhase 36501
37Central Nervous System DepressantsPhase 313403
38GABA AgentsPhase 31684
39EtiracetamPhase 3207
40Cytochrome P-450 CYP3A InducersPhase 31119
41VaccinesPhase 26611
42MF59 oil emulsionPhase 2104
43
LactitolPhase 2336585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
44Adjuvants, ImmunologicPhase 22554
45
Mentholapproved26062216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
46Immunoglobulins6394
47Sulfalene84
48Antibodies6394
49Dermatologic Agents5806
50Bronchodilator Agents2965

Interventional clinical trials:

(show all 12)
idNameStatusNCT IDPhase
1Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVOCompletedNCT01580020Phase 4
2Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed EpilepsyCompletedNCT00175903Phase 3
3Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic Clonic SeizuresEnrolling by invitationNCT02408549Phase 3
4Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic PatientsTerminatedNCT00642421Phase 3
5Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and AboveCompletedNCT00620815Phase 2
6Genetic & Environmental Determinants Of Immune Phenotype Variance: Establishing A Path Towards Personalized MedicineCompletedNCT01699893
7Effect of a Mixture of Probiotics on the Antigen Specific Antibody Response in a Influenza Vaccination Model of Healthy AdultsCompletedNCT01652066
8Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or CuredCompletedNCT02909023
9Sleep and Memory in ChildrenRecruitingNCT02785328
10Uncontrolled Lower Respiratory Symptoms in the WTC Survivor ProgramRecruitingNCT02024204
11Incretin-mimetic Hypoglycemic Drugs and Severe RetinopathyRecruitingNCT02671864
12Impulsivity in Tourette Syndrome : Behavioral and Neuroimaging StudyRecruitingNCT02960698

Search NIH Clinical Center for Nijmegen Breakage Syndrome


Cochrane evidence based reviews: nijmegen breakage syndrome

Genetic Tests for Nijmegen Breakage Syndrome

About this section

Genetic tests related to Nijmegen Breakage Syndrome:

id Genetic test Affiliating Genes
1 Microcephaly, Normal Intelligence and Immunodeficiency27
2 Nijmegen Breakage Syndrome24 NBN

Anatomical Context for Nijmegen Breakage Syndrome

About this section

MalaCards organs/tissues related to Nijmegen Breakage Syndrome:

36
T cells, B cells, Breast, Skeletal muscle, Brain, Prostate, Liver

Publications for Nijmegen Breakage Syndrome

About this section

Articles related to Nijmegen Breakage Syndrome:

(show top 50)    (show all 197)
idTitleAuthorsYear
1
Contribution of Double-strand Break Repair Gene Nijmegen Breakage Syndrome 1 Genotypes, Gender Difference and Smoking Status to Taiwanese Lung Cancer. (28476809)
2017
2
T-lymphoblastic leukemia/lymphoma in macedonian patients with Nijmegen breakage syndrome. (27785413)
2016
3
Clinical course and therapeutic implications for lymphoid malignancies in Nijmegen breakage syndrome. (26826318)
2016
4
Circulating T Cells of Patients with Nijmegen Breakage Syndrome Show Signs of Senescence. (28000062)
2016
5
Chromosomal Instability and Molecular Defects in Induced Pluripotent Stem Cells from Nijmegen Breakage Syndrome Patients. (27545893)
2016
6
Oxidative stress, mitochondrial abnormalities and antioxidant defense in Ataxia-telangiectasia, Bloom syndrome and Nijmegen breakage syndrome. (28063379)
2016
7
Nijmegen breakage syndrome protein 1 (NBS1) modulates hypoxia inducible factor-1I+ (HIF-1I+) stability and promotes in vitro migration and invasion under ionizing radiation. (25959252)
2015
8
Directed Alternative Splicing in Nijmegen Breakage Syndrome: Proof of Principle Concerning Its Therapeutical Application. (26265251)
2015
9
Reduced-intensity conditioning umbilical cord blood transplantation in Nijmegen breakage syndrome. (25523867)
2015
10
Nijmegen breakage syndrome detected by newborn screening for T cell receptor excision circles (TRECs). (25677497)
2015
11
Generation of iPSC lines from a Nijmegen Breakage Syndrome patient. (26987925)
2015
12
Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis. (26271390)
2015
13
Radiation-induced telomere length variations in normal and in Nijmegen Breakage Syndrome cells. (24168161)
2014
14
An adult patient with Nijmegen Breakage Syndrome and Hodgkin's Lymphoma. (24428841)
2014
15
Clinical significance of increased expression of Nijmegen breakage syndrome gene (NBS1) in human primary liver cancer. (26202506)
2014
16
Nijmegen breakage syndrome fibroblasts expressing the C-terminal truncated NBN(p70) protein undergo p38/MK2-dependent premature senescence. (25214013)
2014
17
The role of nibrin in doxorubicin-induced apoptosis and cell senescence in Nijmegen Breakage Syndrome patients lymphocytes. (25119968)
2014
18
The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression. (24510842)
2014
19
Secondary acute monocytic leukemia positive for 11q23 rearrangement in Nijmegen breakage syndrome. (24619942)
2014
20
Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line. (24928521)
2014
21
Celiac-like sprue in Nijmegen breakage syndrome: successful treatment with budesonide. (24834778)
2014
22
Nijmegen breakage syndrome and chronic polyarthritis. (24044622)
2013
23
Nijmegen breakage syndrome: the clearance pathway for mutant nibrin protein is allele specific. (23458873)
2013
24
Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk. (23765759)
2013
25
Regulation of the Nijmegen breakage syndrome 1 gene NBS1 by c-myc, p53 and coactivators mediates estrogen protection from DNA damage in breast cancer cells. (23291854)
2013
26
Cutaneous sarcoid-like granulomas in a child known with nijmegen breakage syndrome. (23550270)
2013
27
Mutation Inactivation of Nijmegen Breakage Syndrome Gene (NBS1) in Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. (24349281)
2013
28
Necrobiotic cutaneous granulomas in Nijmegen breakage syndrome. (22533239)
2012
29
Nijmegen breakage syndrome with macrocephaly, schizencephaly and large CSF spacesa89extended spectrum of the condition. (22293976)
2012
30
Nijmegen breakage syndrome (NBS). (22373003)
2012
31
DNA damage in Nijmegen Breakage Syndrome cells leads to PARP hyperactivation and increased oxidative stress. (22396666)
2012
32
Haploinsufficiency of the Nijmegen breakage syndrome 1 gene increases mammary tumor latency and metastasis. (22576691)
2012
33
The defect in humoral immunity in patients with Nijmegen breakage syndrome is explained by defects in peripheral B lymphocyte maturation. (22851427)
2012
34
Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey. (21923652)
2011
35
Astrocyte dysfunction associated with cerebellar attrition in a Nijmegen breakage syndrome animal model. (21279473)
2011
36
Nijmegen breakage syndrome (NBS) as a risk factor for CNS involvement in childhood acute lymphoblastic leukemia. (21557461)
2011
37
Two unrelated patients with MRE11A mutations and Nijmegen breakage syndrome-like severe microcephaly. (21227757)
2011
38
Nijmegen breakage syndrome complicated with primary cutaneous tuberculosis. (20924312)
2011
39
Nijmegen breakage syndrome: Long-term monitoring of viral and immunological biomarkers in peripheral blood before development of malignancy. (20167538)
2010
40
Chronic noninfectious necrotizing granulomas in a child with Nijmegen breakage syndrome. (20609147)
2010
41
Clinical variability and novel mutations in the NHEJ1 gene in patients with a Nijmegen breakage syndrome-like phenotype. (20597108)
2010
42
Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide. (20729302)
2010
43
Telomerase upregulation is a postcrisis event during senescence bypass and immortalization of two Nijmegen breakage syndrome T cell cultures. (20089118)
2010
44
High prevalence of primary ovarian insufficiency in girls and young women with Nijmegen breakage syndrome: evidence from a longitudinal study. (20444919)
2010
45
Successful SCT for Nijmegen breakage syndrome. (19684627)
2010
46
A novel defect in mitochondrial p53 accumulation following DNA damage confers apoptosis resistance in Ataxia Telangiectasia and Nijmegen Breakage Syndrome T-cells. (20947454)
2010
47
Inactivation of the Nijmegen breakage syndrome gene leads to excess centrosome duplication via the ATR/BRCA1 pathway. (19244116)
2009
48
Successful treatment of hodgkin lymphoma in nijmegen breakage syndrome. (19125088)
2009
49
Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS). (18937313)
2009
50
Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations. (19151620)
2009

Variations for Nijmegen Breakage Syndrome

About this section

Clinvar genetic disease variations for Nijmegen Breakage Syndrome:

5 (show all 65)
id Gene Variation Type Significance SNP ID Assembly Location
1NBNNM_ 002485.4(NBN): c.698_ 701delAACA (p.Lys233Serfs)deletionPathogenicrs587780100GRCh37Chr 8, 90983402: 90983405
2NBNNM_ 002485.4(NBN): c.88_ 89delAA (p.Asn30Leufs)deletionPathogenic/ Likely pathogenicrs587781718GRCh37Chr 8, 90995032: 90995033
3NBNNM_ 002485.4(NBN): c.123delC (p.Ser42Alafs)deletionPathogenicrs587781891GRCh37Chr 8, 90994998: 90994998
4NBNNM_ 002485.4(NBN): c.1142delC (p.Pro381Glnfs)deletionPathogenicrs587781969GRCh37Chr 8, 90967766: 90967766
5NBNNM_ 002485.4(NBN): c.127C> T (p.Arg43Ter)SNVPathogenic/ Likely pathogenicrs200287925GRCh38Chr 8, 89982766: 89982766
6NBNNM_ 002485.4(NBN): c.1903A> T (p.Lys635Ter)SNVPathogenic/ Likely pathogenicrs587782545GRCh37Chr 8, 90960063: 90960063
7NBNNM_ 002485.4(NBN): c.1397+2T> ASNVPathogenic/ Likely pathogenicrs730881850GRCh37Chr 8, 90967509: 90967509
8NBNNM_ 002485.4(NBN): c.2117C> G (p.Ser706Ter)SNVPathogenic/ Likely pathogenicrs730881857GRCh37Chr 8, 90955548: 90955548
9NBNNM_ 002485.4(NBN): c.2140C> T (p.Arg714Ter)SNVPathogenicrs730881864GRCh38Chr 8, 89943297: 89943297
10NBNNM_ 002485.4(NBN): c.1723G> T (p.Glu575Ter)SNVPathogenicrs786201745GRCh37Chr 8, 90965594: 90965594
11NBNNM_ 002485.4(NBN): c.2071-1G> CSNVPathogenic/ Likely pathogenicrs786201965GRCh37Chr 8, 90955595: 90955595
12NBNNM_ 002485.4(NBN): c.808_ 809delGT (p.Val270Cysfs)deletionPathogenicrs786202490GRCh37Chr 8, 90982679: 90982680
13NBNNM_ 002485.4(NBN): c.210_ 211delTA (p.Asp70Glufs)deletionPathogenicrs786202494GRCh37Chr 8, 90993712: 90993713
14NBNNM_ 002485.4(NBN): c.37+1G> ASNVLikely pathogenicrs574673404GRCh37Chr 8, 90996752: 90996752
15NBNNM_ 002485.4(NBN): c.2165G> A (p.Trp722Ter)SNVPathogenicrs786204181GRCh37Chr 8, 90955500: 90955500
16NBNNM_ 002485.4(NBN): c.842T> G (p.Leu281Ter)SNVPathogenicrs786205135GRCh38Chr 8, 89970418: 89970418
17NBNNM_ 002485.4(NBN): c.1030C> T (p.Gln344Ter)SNVPathogenic/ Likely pathogenicrs767215758GRCh38Chr 8, 89958819: 89958819
18NBNNM_ 002485.4(NBN): c.2185-?_ *(1_ ?)deldeletionLikely pathogenicGRCh37Chr 8, 90947809: 90949303
19NBNNM_ 002485.4(NBN): c.211_ 212insGA (p.Asn71Argfs)insertionPathogenicrs762664474GRCh38Chr 8, 89981483: 89981484
20NBNNM_ 002485.4(NBN): c.897-?_ 2184+?deldeletionPathogenicGRCh37Chr 8, 90955481: 90976735
21NBNNM_ 002485.4(NBN): c.897-2A> TSNVLikely pathogenicrs864622090GRCh37Chr 8, 90976737: 90976737
22NBNNM_ 002485.4(NBN): c.1747C> T (p.Gln583Ter)SNVPathogenicrs864622143GRCh38Chr 8, 89953342: 89953342
23NBNNM_ 002485.4(NBN): c.93_ 94delTG (p.Ala32Hisfs)deletionPathogenicrs864622253GRCh37Chr 8, 90995027: 90995028
24NBNNM_ 002485.4(NBN): c.1419_ 1431dupAGAAATGTCTTCA (p.Cys478Argfs)duplicationPathogenicrs864622333GRCh38Chr 8, 89953658: 89953670
25NBNNM_ 002485.4(NBN): c.115delC (p.Gln39Serfs)deletionPathogenicrs864622511GRCh37Chr 8, 90995006: 90995006
26NBNNM_ 002485.4(NBN): c.995-2A> GSNVPathogenic/ Likely pathogenicrs876659521GRCh37Chr 8, 90971084: 90971084
27NBNNM_ 002485.4(NBN): c.1651dupA (p.Arg551Lysfs)duplicationPathogenicrs766044684GRCh37Chr 8, 90965666: 90965666
28NBNNM_ 002485.4(NBN): c.265C> T (p.Arg89Ter)SNVLikely pathogenicrs1057516320GRCh37Chr 8, 90993658: 90993658
29NBNNM_ 002485.4(NBN): c.171+1G> ASNVLikely pathogenicrs931715719GRCh37Chr 8, 90994949: 90994949
30NBNNM_ 002485.4(NBN): c.1587dupA (p.Ser530Ilefs)duplicationLikely pathogenicrs1057516332GRCh38Chr 8, 89953502: 89953502
31NBNNM_ 002485.4(NBN): c.178dupA (p.Thr60Asnfs)duplicationLikely pathogenicrs1057516392GRCh38Chr 8, 89981517: 89981517
32NBNNM_ 002485.4(NBN): c.1848delA (p.Glu617Lysfs)deletionLikely pathogenicrs1057516611GRCh38Chr 8, 89947890: 89947890
33NBNNM_ 002485.4(NBN): c.1974delA (p.Glu658Aspfs)deletionLikely pathogenicrs1057516668GRCh38Chr 8, 89946236: 89946236
34NBNNM_ 002485.4(NBN): c.163_ 171+3del12deletionLikely pathogenicrs1057516772GRCh38Chr 8, 89982719: 89982730
35NBNNM_ 002485.4(NBN): c.531delT (p.Phe177Leufs)deletionLikely pathogenicrs1057516787GRCh37Chr 8, 90990501: 90990501
36NBNNM_ 002485.4(NBN): c.317dupT (p.Arg107Glnfs)duplicationLikely pathogenicrs745355767GRCh37Chr 8, 90993606: 90993606
37NBNNM_ 002485.4(NBN): c.2000_ 2001delCT (p.Ser667Tyrfs)deletionLikely pathogenicrs1057516852GRCh37Chr 8, 90958437: 90958438
38NBNNM_ 002485.4(NBN): c.2049_ 2050delAAinsT (p.Lys683Asnfs)indelLikely pathogenicrs1057516869GRCh38Chr 8, 89946160: 89946161
39NBNNM_ 002485.4(NBN): c.1640delC (p.Ser547Terfs)deletionLikely pathogenicrs776417262GRCh38Chr 8, 89953449: 89953449
40NBNNM_ 002485.4(NBN): c.156_ 157delTT (p.Ser53Cysfs)deletionPathogenic/ Likely pathogenicrs767454740GRCh38Chr 8, 89982736: 89982737
41NBNNM_ 002485.4(NBN): c.2070+2delTdeletionLikely pathogenicrs1057517075GRCh37Chr 8, 90958366: 90958366
42NBNNM_ 002485.4(NBN): c.1125-1G> ASNVLikely pathogenicrs1057517102GRCh37Chr 8, 90967784: 90967784
43NBNNM_ 002485.4(NBN): c.702+1G> ASNVLikely pathogenicrs1057517104GRCh37Chr 8, 90983400: 90983400
44NBNNM_ 002485.4(NBN): c.1124+1G> ASNVLikely pathogenicrs1057517209GRCh37Chr 8, 90970952: 90970952
45NBNNM_ 002485.4(NBN): c.1846-1G> ASNVLikely pathogenicrs61753717GRCh37Chr 8, 90960121: 90960121
46NBNNM_ 002485.4(NBN): c.2185-1G> ASNVLikely pathogenicrs1057517262GRCh38Chr 8, 89937076: 89937076
47NBNNM_ 002485.4(NBN): c.330T> G (p.Tyr110Ter)SNVPathogenicrs1057519585GRCh37Chr 8, 90993112: 90993112
48NBNNM_ 002485.4(NBN): c.681delT (p.Phe227LeufsTer4)deletionPathogenicrs1057519586GRCh37Chr 8, 90983422: 90983422
49NBNNM_ 002485.4(NBN): c.900_ 924del25 (p.Gly301LysfsTer5)deletionPathogenicrs1057519587GRCh37Chr 8, 90976708: 90976732
50NBNNM_ 002485.4(NBN): c.1125G> A (p.Trp375Ter)SNVPathogenicrs1057519588GRCh37Chr 8, 90967783: 90967783
51NBNNM_ 002485.4(NBN): c.383T> G (p.Leu128Ter)SNVPathogenicrs1060503463GRCh38Chr 8, 89980831: 89980831
52NBNNM_ 002485.4(NBN): c.1038_ 1039dupGT (p.Ser347Cysfs)duplicationPathogenicGRCh38Chr 8, 89958810: 89958811
53NBNNM_ 002485.4(NBN): c.1854_ 1857delTGAA (p.Asn618Lysfs)deletionPathogenicrs1060503466GRCh38Chr 8, 89947881: 89947884
54NBNNM_ 002485.4(NBN): c.1397+1delGdeletionLikely pathogenicrs1060503467GRCh38Chr 8, 89955282: 89955282
55NBNNM_ 002485.4(NBN): c.1553C> G (p.Ser518Ter)SNVPathogenicrs1060503480GRCh38Chr 8, 89953536: 89953536
56NBNNM_ 002485.4(NBN): c.1647_ 1651delAAAAA (p.Lys550Glyfs)deletionPathogenicrs1060503481GRCh38Chr 8, 89953438: 89953442
57NBNNM_ 002485.4(NBN): c.1716dupA (p.Glu573Argfs)duplicationPathogenic/ Likely pathogenicGRCh38Chr 8, 89953373: 89953373
58NBNNM_ 002485.4(NBN): c.26delG (p.Gly9Alafs)deletionPathogenicrs1060503485GRCh38Chr 8, 89984536: 89984536
59NBNNC_ 000008.11: g.(?_ 89980734)_ (89984671_ ?)deldeletionPathogenicGRCh37Chr 8, 90992962: 90996899
60NBNNM_ 002485.4(NBN): c.657_ 661delACAAA (p.Lys219Asnfs)deletionPathogenic, risk factorrs587776650GRCh37Chr 8, 90983442: 90983446
61NBNNM_ 002485.4(NBN): c.835_ 838delCAGA (p.Gln279Profs)deletionPathogenicrs864309668GRCh38Chr 8, 89970422: 89970425
62NBNNM_ 002485.4(NBN): c.842dupT (p.Leu281Phefs)duplicationPathogenicrs864309669GRCh38Chr 8, 89970418: 89970418
63NBNNM_ 002485.4(NBN): c.976C> T (p.Gln326Ter)SNVPathogenicrs121908973GRCh37Chr 8, 90976656: 90976656
64NBNNM_ 002485.4(NBN): c.1089C> A (p.Tyr363Ter)SNVPathogenicrs121908974GRCh37Chr 8, 90970988: 90970988
65NBNNM_ 002485.4(NBN): c.741_ 742dupGG (p.Glu248Glyfs)duplicationPathogenicrs864309670GRCh37Chr 8, 90982746: 90982747

Expression for genes affiliated with Nijmegen Breakage Syndrome

About this section
Search GEO for disease gene expression data for Nijmegen Breakage Syndrome.

Pathways for genes affiliated with Nijmegen Breakage Syndrome

About this section

Pathways related to Nijmegen Breakage Syndrome according to GeneCards Suite gene sharing:

(show all 41)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.4MRE11, NBN, RAD50
2
Show member pathways
9.3ATM, TP53
39.3BRCA1, TP53
49.1CHEK2, TP53
5
Show member pathways
9.1ATM, MRE11, NBN, RAD50
69.1ATM, CHEK2, H2AFX
79.0ATM, BRCA1, TP53
89.0ATM, BRCA1, TP53
99.0ATM, BRCA1, TP53
108.8ATM, H2AFX, TP53
11
Show member pathways
8.8ATM, CHEK2, TP53
12
Show member pathways
8.8ATM, CHEK2, TP53
13
Show member pathways
8.8ATM, CHEK2, TP53
14
Show member pathways
8.8ATM, CHEK2, TP53
158.7ATM, MRE11, NBN, RAD50, WRN
16
Show member pathways
8.4ATM, BRCA1, CHEK2, TP53
178.4ATM, BRCA1, CHEK2, TP53
18
Show member pathways
8.3ATM, BRCA1, MRE11, NBN, RAD50, WRN
19
Show member pathways
8.3ATM, BRCA1, MRE11, NBN, RAD50, WRN
208.3BRCA1, LIG4, MRE11, NBN, RAD50, WRN
21
Show member pathways
8.2BRCA1, MDC1, TP53, WRN
22
Show member pathways
8.2ATM, BRCA1, H2AFX, MRE11, NBN, RAD50
237.9ATM, BRCA1, MRE11, NBN, RAD50, TP53
24
Show member pathways
7.8ATM, H2AFX, MRE11, NBN, RAD50, TP53
25
Show member pathways
7.8ATM, H2AFX, MRE11, NBN, RAD50, TP53
267.7ATM, BRCA1, CHEK2, MRE11, RAD50, TP53
277.7ATM, BRCA1, CHEK2, MRE11, RAD50, TP53
287.5ATM, BRCA1, CHEK2, MDC1, NBN, TP53
297.4ATM, CHEK2, H2AFX, MDC1, MRE11, NBN
30
Show member pathways
7.4ATM, BRCA1, CHEK2, MRE11, NBN, RAD50
31
Show member pathways
7.1ATM, BRCA1, CHEK2, LIG4, MRE11, NBN
32
Show member pathways
6.9ATM, BRCA1, CHEK2, H2AFX, MRE11, NBN
33
Show member pathways
6.4ATM, BRCA1, CHEK2, MDC1, MRE11, NBN
34
Show member pathways
6.3ATM, BRCA1, CHEK2, H2AFX, MDC1, MRE11
35
Show member pathways
6.3ATM, BRCA1, CHEK2, H2AFX, MDC1, MRE11
366.1ATM, BRCA1, CHEK2, H2AFX, LIG4, MRE11
37
Show member pathways
5.9ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1
38
Show member pathways
5.8ATM, BRCA1, CHEK2, H2AFX, MDC1, MRE11
39
Show member pathways
5.8ATM, BRCA1, CHEK2, H2AFX, MDC1, MRE11
40
Show member pathways
5.8ATM, BRCA1, CHEK2, H2AFX, MDC1, MRE11
41
Show member pathways
5.5ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1

GO Terms for genes affiliated with Nijmegen Breakage Syndrome

About this section

Cellular components related to Nijmegen Breakage Syndrome according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1condensed chromosomeGO:000079310.6BRCA1, LIG4
2Mre11 complexGO:003087010.3MRE11, NBN, RAD50
3condensed nuclear chromosomeGO:000079410.1BRCA1, H2AFX, RAD50
4nuclear chromatinGO:00007909.7H2AFX, RAD50, TP53
5nuclear chromosome, telomeric regionGO:00007849.6ATM, LIG4, MRE11, NBN, RAD50
6site of double-strand breakGO:00358618.9H2AFX, MRE11, NBN, RAD50
7PML bodyGO:00166058.9CHEK2, MRE11, NBN, TP53
8replication forkGO:00056578.9H2AFX, NBN, TP53, WRN
9chromosome, telomeric regionGO:00007818.5ATM, CHEK2, H2AFX, MRE11, NBN, RAD50
10chromosomeGO:00056948.3BRCA1, H2AFX, MDC1, MRE11, NBN, RAD50
11nucleoplasmGO:00056546.3ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1
12nucleusGO:00056346.1ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1

Biological processes related to Nijmegen Breakage Syndrome according to GeneCards Suite gene sharing:

(show top 50)    (show all 55)
idNameGO IDScoreTop Affiliating Genes
1chromosome organization involved in meiotic cell cycleGO:007019210.6ATM, RAD50
2isotype switchingGO:004519010.6LIG4, NBN
3neuron apoptotic processGO:005140210.5ATM, LIG4
4mitotic G2 DNA damage checkpointGO:000709510.5MRE11, NBN
5V(D)J recombinationGO:003315110.5ATM, LIG4
6t-circle formationGO:009065610.4NBN, WRN
7chromosome organizationGO:005127610.4LIG4, MRE11
8regulation of mitotic recombinationGO:000001910.4MRE11, RAD50
9DNA damage induced protein phosphorylationGO:000697510.4ATM, CHEK2
10negative regulation of telomere cappingGO:190435410.3ATM, NBN, RAD50
11positive regulation of DNA repairGO:004573910.3BRCA1, H2AFX
12replicative cell agingGO:000130210.2CHEK2, WRN
13positive regulation of kinase activityGO:003367410.1MRE11, NBN, RAD50
14positive regulation of protein autophosphorylationGO:003195410.1MRE11, NBN, RAD50
15positive regulation of telomere maintenanceGO:003220610.1MRE11, NBN, RAD50
16telomere maintenanceGO:000072310.1NBN, RAD50, WRN
17DNA damage response, signal transduction by p53 class mediatorGO:003033010.1NBN, TP53
18intra-S DNA damage checkpointGO:003157310.1MDC1, MRE11
19reciprocal meiotic recombinationGO:000713110.1ATM, MRE11, RAD50
20intrinsic apoptotic signaling pathwayGO:009719310.1NBN, TP53
21determination of adult lifespanGO:000834010.1ATM, TP53
22telomeric 3 overhang formationGO:003186010.1MRE11, NBN, RAD50
23telomere maintenance via telomeraseGO:000700410.0ATM, MRE11, RAD50
24base-excision repairGO:000628410.0TP53, WRN
25cell agingGO:000756910.0TP53, WRN
26nucleic acid phosphodiester bond hydrolysisGO:009030510.0MRE11, RAD50, WRN
27positive regulation of cell cycle arrestGO:007115810.0BRCA1, TP53
28intrinsic apoptotic signaling pathway in response to DNA damageGO:000863010.0ATM, BRCA1, CHEK2
29response to X-rayGO:001016510.0LIG4, TP53
30DNA damage checkpointGO:00000779.9CHEK2, H2AFX, NBN
31intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorGO:00427719.9CHEK2, TP53
32cell cycle arrestGO:00070509.8ATM, NBN, TP53
33DNA duplex unwindingGO:00325089.8MRE11, NBN, RAD50, WRN
34meiotic cell cycleGO:00513219.6H2AFX, MRE11, NBN, RAD50
35response to ionizing radiationGO:00102129.6ATM, BRCA1, H2AFX, LIG4
36DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestGO:00069779.6ATM, CHEK2, TP53
37DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorGO:00069789.5BRCA1, CHEK2, TP53
38DNA double-strand break processingGO:00007299.5ATM, BRCA1, MRE11, NBN, RAD50
39replicative senescenceGO:00903999.5ATM, CHEK2, TP53
40response to gamma radiationGO:00103329.5CHEK2, LIG4, TP53
41cell proliferationGO:00082839.3LIG4, MRE11, NBN, TP53
42DNA synthesis involved in DNA repairGO:00007319.1ATM, BRCA1, MRE11, NBN, RAD50, WRN
43strand displacementGO:00007329.0ATM, BRCA1, MRE11, NBN, RAD50, WRN
44DNA recombinationGO:00063108.8BRCA1, H2AFX, LIG4, MRE11, RAD50, WRN
45DNA replicationGO:00062608.7ATM, BRCA1, LIG4, MRE11, NBN, RAD50
46regulation of apoptotic processGO:00429818.7ATM, BRCA1, CHEK2, TP53, WRN
47cellular response to gamma radiationGO:00714808.6ATM, CHEK2, H2AFX, TP53, WRN
48double-strand break repair via homologous recombinationGO:00007248.5ATM, BRCA1, H2AFX, MRE11, NBN, RAD50
49viral processGO:00160328.4H2AFX, MRE11, RAD50, TP53
50double-strand break repairGO:00063028.0BRCA1, CHEK2, H2AFX, LIG4, MRE11, NBN

Molecular functions related to Nijmegen Breakage Syndrome according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1G-quadruplex DNA bindingGO:005188010.6RAD50, WRN
23-5 exonuclease activityGO:000840810.1MRE11, RAD50, WRN
3ATP-dependent DNA helicase activityGO:00040039.9MRE11, NBN, RAD50, WRN
4nucleotide bindingGO:00001669.8ATM, CHEK2, LIG4, RAD50
5single-stranded DNA endodeoxyribonuclease activityGO:00000149.7MRE11, RAD50
6protein C-terminus bindingGO:00080229.6LIG4, MDC1, MRE11
7damaged DNA bindingGO:00036849.3BRCA1, H2AFX, NBN, TP53
8protein N-terminus bindingGO:00474859.2ATM, NBN, TP53
9ATP bindingGO:00055248.6ATM, CHEK2, LIG4, RAD50, TP53, WRN
10DNA bindingGO:00036777.7ATM, BRCA1, H2AFX, LIG4, MRE11, RAD50
11protein bindingGO:00055156.1ATM, BRCA1, CHEK2, H2AFX, LIG4, MDC1

Sources for Nijmegen Breakage Syndrome

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet